European evidence based consensus for endoscopy in inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 7, Issue 12, 2013, Pages 982-1018

  Annese, Vito ^a   Daperno, Marco ^b   Rutter, Matthew D ^c,q   Amiot, Aurelien ^d   Bossuyt, Peter ^e   East, James ^f   Ferrante, Marc ^g   Götz, Martin ^h   Katsanos, Konstantinos H ⁱ   Kießlich, Ralf ^j   Ordás, Ingrid ^k   Repici, Alessandro ^l   Rosa, Bruno ^m   Sebastian, Shaji ⁿ   Kucharzik, Torsten ^o   Eliakim, Rami ^p  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

^c UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^d DURHAM UNIVERSITY   (United Kingdom)

^e HENRI MONDOR HOSPITAL   (France)

^f Gastroenterology   (Belgium)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁱ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^j UNIVERSITY OF IOANNINA   (Greece)

^k JOHANNES GUTENBERG UNIVERSITY   (Germany)

^l HOSPITAL CLÍNIC   (Spain)

^m HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

ⁿ Gastroenterology   (Portugal)

^o HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^p Municipal Hospital of Lueneburg   (Germany)

^q SHEBA MEDICAL CENTER   (Israel)

more..

Author keywords

Colorectal cancer (CRC); Crohn's disease (CD); Endoscopy; Ulcerative colitis (UC)

Indexed keywords

CYCLOSPORIN; INFLIXIMAB;

ARTICLE; CAPSULE ENDOSCOPY; COLITIS; COLONOSCOPY; CONSENSUS; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DYSPLASIA; ENDOSCOPIC BIOPSY; ENDOSCOPY; ENTERITIS; EUROPE; EVIDENCE BASED PRACTICE; FOLLOW UP; GOLD STANDARD; HEALTH CARE QUALITY; HUMAN; ILEOCOLONOSCOPY; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROGNOSIS; RECTUM; RECURRENT DISEASE; REMISSION; REPEAT PROCEDURE; RISK FACTOR; SCORING SYSTEM; ULCERATIVE COLITIS; UPPER GASTROINTESTINAL TRACT;

COLORECTAL CANCER (CRC); CROHN'S DISEASE (CD); ENDOSCOPY; ULCERATIVE COLITIS (UC);

ACUTE DISEASE; BIOPSY; COLON; COLONIC POUCHES; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY, GASTROINTESTINAL; HUMANS; ILEUM; INFLAMMATORY BOWEL DISEASES; POPULATION SURVEILLANCE; RECTUM; SEVERITY OF ILLNESS INDEX;

EID: 84887552451     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.09.016     Document Type: Article

References (430)

1. Leighton J.A., Shen B., Baron T.H., Adler D.G., Davila R., Egan J.V., et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc 2006, 63:558-565.
2. Bourreille A., Ignjatovic A., Aabakken L., Loftus E.V., Eliakim R., Pennazio M., et al. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy 2009, 41:618-637.
3. Fink A., Kosecoff J., Chassin M., Brook R.H. Consensus methods: characteristics and guidelines for use. Am J Public Health 1984, 74:979-983.
4. http://www.cebm.net/mod_product/design/files/CEBM-Levels-of-Evidence-2.1.pdf.
5. Manes G., Imbesi V., Ardizzone S., Cassinotti A., Bosani M., Massari A., et al. Appropriateness and diagnostic yield of colonoscopy in the management of patients with ulcerative colitis: a prospective study in an open access endoscopy service. Inflamm Bowel Dis 2008, 14:1133-1138.
6. Markowitz J., Kahn E., Grancher K., Hyams J., Treem W., Daum F. Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis. Am J Gastroenterol 1993, 88:2034-2037.
7. Robert M.E., Skacel M., Ullman T., Bernstein C.N., Easley K., Goldblum J.R. Patterns of colonic involvement at initial presentation in ulcerative colitis: a retrospective study of 46 newly diagnosed cases. Am J Clin Pathol 2004, 122:94-99.
8. Robert M.E., Tang L., Hao L.M., Reyes-Mugica M. Patterns of inflammation in mucosal biopsies of ulcerative colitis: perceived differences in pediatric populations are limited to children younger than 10years. Am J Surg Pathol 2004, 28:183-189.
9. Rajwal S.R., Puntis J.W., McClean P., Davison S.M., Newell S.J., Sugarman I., et al. Endoscopic rectal sparing in children with untreated ulcerative colitis. J Pediatr Gastroenterol Nutr 2004, 38:66-69.
10. Odze R., Antonioli D., Peppercorn M., Goldman H. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol 1993, 17:869-875.
11. D'Haens G., Geboes K., Peeters M., Baert F., Ectors N., Rutgeerts P. Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. Am J Gastroenterol 1997, 92:1275-1279.
12. Mutinga M.L., Odze R.D., Wang H.H., Hornick J.L., Farraye F.A. The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis. Inflamm Bowel Dis 2004, 10:215-219.
13. Kim B., Barnett J.L., Kleer C.G., Appelman H.D. Endoscopic and histological patchiness in treated ulcerative colitis. Am J Gastroenterol 1999, 94:3258-3262.
14. Byeon J.S., Yang S.K., Myung S.J., Pyo S.I., Park H.J., Kim Y.M., et al. Clinical course of distal ulcerative colitis in relation to appendiceal orifice inflammation status. Inflamm Bowel Dis 2005, 11:366-371.
15. Ladefoged K., Munck L.K., Jorgensen F., Engel P. Skip inflammation of the appendiceal orifice: a prospective endoscopic study. Scand J Gastroenterol 2005, 40:1192-1196.
16. Yang S.K., Jung H.Y., Kang G.H., Kim Y.M., Myung S.J., Shim K.N., et al. Appendiceal orifice inflammation as a skip lesion in ulcerative colitis: an analysis in relation to medical therapy and disease extent. Gastrointest Endosc 1999, 49:743-747.
17. Matsumoto T., Nakamura S., Shimizu M., Iida M. Significance of appendiceal involvement in patients with ulcerative colitis. Gastrointest Endosc 2002, 55:180-185.
18. Haskell H., Andrews C.W., Reddy S.I., Dendrinos K., Farraye F.A., Stucchi A.F., et al. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol 2005, 29:1472-1481.
19. Goldstein N., Dulai M. Contemporary morphologic definition of backwash ileitis in ulcerative colitis and features that distinguish it from Crohn disease. Am J Clin Pathol 2006, 126:365-376.
20. Abdelrazeq A.S., Wilson T.R., Leitch D.L., Lund J.N., Leveson S.H. Ileitis in ulcerative colitis: is it a backwash?. Dis Colon Rectum 2005, 48:2038-2046.
21. Geboes K., Ectors N., D'Haens G., Rutgeerts P. Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease?. Am J Gastroenterol 1998, 93:201-206.
22. Van Assche G., Dignass A., Panes J., Beaugerie L., Karagiannis J., Allez M., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010, 4:7-27.
23. Navaneethan U., Parasa S., Venkatesh P.G., Trikudanathan G., Shen B. Prevalence and risk factors for colonic perforation during colonoscopy in hospitalized inflammatory bowel disease patients. J Crohns Colitis 2011, 5:189-195.
24. Navaneethan U., Kochhar G., Phull H., Venkatesh P.G., Remzi F.H., Kiran R.P., et al. Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients. J Crohns Colitis 2012, 6:470-475.
25. Buisson A., Chevaux J.B., Hudziak H., Bresler L., Bigard M.A., Peyrin-Biroulet L. Colonoscopic perforations in inflammatory bowel disease: a retrospective study in a French referral centre. Dig Liver Dis 2013, 45:569-572.
26. Levine A., Griffiths A., Markowitz J., Wilson D.C., Turner D., Russell R.K., et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011, 17:1314-1321.
27. Castellaneta S.P., Afzal N.A., Greenberg M., Deere H., Davies S., Murch S.H., et al. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2004, 39:257-261.
28. Crocco S., Martelossi S., Giurici N., Villanacci V., Ventura A. Upper gastrointestinal involvement in paediatric onset Crohn's disease: prevalence and clinical implications. J Crohns Colitis 2012, 6:51-55.
29. Annunziata M.L., Caviglia R., Papparella L.G., Cicala M. Upper gastrointestinal involvement of Crohn's disease: a prospective study on the role of upper endoscopy in the diagnostic work-up. Dig Dis Sci 2012, 57:1618-1623.
30. Rutgeerts P., Onette E., Vantrappen G., Geboes K., Broeckaert L., Talloen L. Crohn's disease of the stomach and duodenum: a clinical study with emphasis on the value of endoscopy and endoscopic biopsies. Endoscopy 1980, 12:288-294.
31. Turner D., Griffiths A.M. Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis. Curr Gastroenterol Rep 2007, 9:475-478.
32. Casella G., D'Inca R., Oliva L., Daperno M., Saladino V., Zoli G., et al. Prevalence of celiac disease in inflammatory bowel diseases: an IG-IBD multicentre study. Dig Liver Dis 2010, 42:175-178.
33. Altschuler A., Collins B., Lewis J.D., Velayos F., Allison J.E., Hutfless S., et al. Gastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:992-999.
34. Travis S.P., Schnell D., Krzeski P., Abreu M.T., Altman D.G., Colombel J.F., et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 2012, 61:535-542.
35. Thia K.T., Loftus E.V., Pardi D.S., Kane S.V., Faubion W.A., Tremaine W.J., et al. Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity. Inflamm Bowel Dis 2011, 17:1257-1264.
36. Feagan B.G., Greenberg G.R., Wild G., Fedorak R.N., Pare P., McDonald J.W., et al. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl J Med 2005, 352:2499-2507.
37. Travis S.P., Schnell D., Krzeski P., Abreu M.T., Altman D.G., Colombel J.F., et al. Reliability and initial validation of the Ulcerative Colitis Endoscopic Index of Severity. Gastroenterology Jul 25 2013, pii: S0016-5085(13)01075-5 (Epub ahead of print). 10.1053/j.gastro.2013.07.024.
38. Dillon M., Brown S., Casey W., Walsh D., Durnin M., Abubaker K., et al. Colonoscopy under general anesthesia in children. Pediatrics 1998, 102:381-383.
39. Magro F., Langner C., Driessen A., Ensari A., Geboes K., Mantzaris G.J., et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013, 7:827-851.
40. Henriksen M., Jahnsen J., Lygren I., Sauar J., Schulz T., Stray N., et al. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol 2006, 41:1037-1043.
41. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
42. Meucci G., Bortoli A., Riccioli F.A., Girelli C.M., Radaelli F., Rivolta R., et al. Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali). Eur J Gastroenterol Hepatol 1999, 11:909-913.
43. Dignass A., Eliakim R., Magro F., Maaser C., Chowers Y., Geboes K., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis 2012, 6:965-990.
44. Jarnerot G. How to judge the response to treatment in ulcerative colitis?. Inflamm Bowel Dis 2008, 14(Suppl. 2):S222-S223.
45. Rutgeerts P., Vermeire S., Van Assche G. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?. Gut 2007, 56:453-455.
46. Lopez-Palacios N., Mendoza J.L., Taxonera C., Lana R., Lopez-Jamar J.M., Diaz-Rubio M. Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy. Eur J Intern Med 2011, 22:621-625.
47. Colombel J.F., Rutgeerts P., Reinisch W., Esser D., Wang Y., Lang Y., et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011, 141:1194-1201.
48. Peyrin-Biroulet L., Ferrante M., Magro F., Campbell S., Franchimont D., Fidder H., et al. Results from the 2nd Scientific Workshop of the ECCO I: impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 2011, 5:477-483.
49. Rutgeerts P., Van Assche G., Sandborn W.J., Wolf D.C., Geboes K., Colombel J.F., et al. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. Gastroenterology 2012, 142(1102-1111):e1102.
50. Fefferman D.S., Farrell R.J. Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. Clin Gastroenterol Hepatol 2005, 3:11-24.
51. Sipponen T., Savilahti E., Karkkainen P., Kolho K.L., Nuutinen H., Turunen U., et al. Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease. Inflamm Bowel Dis 2008, 14:1392-1398.
52. Sipponen T., Savilahti E., Kolho K.L., Nuutinen H., Turunen U., Farkkila M. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 2008, 14:40-46.
53. af Bjorkesten C.G., Nieminen U., Turunen U., Arkkila P., Sipponen T., Farkkila M. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease. Scand J Gastroenterol 2012, 47:528-537.
54. D'Haens G., Ferrante M., Vermeire S., Baert F., Noman M., Moortgat L., et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis 2012, 18:2218-2224.
55. Gisbert J.P., Bermejo F., Perez-Calle J.L., Taxonera C., Vera I., McNicholl A.G., et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 2009, 15:1190-1198.
56. Schoepfer A.M., Beglinger C., Straumann A., Trummler M., Renzulli P., Seibold F. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis 2009, 15:1851-1858.
57. Meucci G., Fasoli R., Saibeni S., Valpiani D., Gullotta R., Colombo E., et al. Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study. Inflamm Bowel Dis 2012, 18:1006-1010.
58. Thakkar K., Lucia C.J., Ferry G.D., McDuffie A., Watson K., Tsou M., et al. Repeat endoscopy affects patient management in pediatric inflammatory bowel disease. Am J Gastroenterol 2009, 104:722-727.
59. Rutgeerts P., Geboes K., Vantrappen G., Kerremans R., Coenegrachts J.L., Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984, 25:665-672.
60. Rutgeerts P., Geboes K., Vantrappen G., Beyls J., Kerremans R., Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990, 99:956-963.
61. Amiot A., Gornet J.M., Baudry C., Munoz-Bongrand N., Auger M., Simon M., et al. Crohn's disease recurrence after total proctocolectomy with definitive ileostomy. Dig Liver Dis 2011, 43:698-702.
62. Kurer M.A., Stamou K.M., Wilson T.R., Bradford I.M., Leveson S.H. Early symptomatic recurrence after intestinal resection in Crohn's disease is unpredictable. Colorectal Dis 2007, 9:567-571.
63. Leal-Valdivieso C., Marin I., Manosa M., Naves J.E., Zabana Y., Pinol M., et al. Should we monitor Crohn's disease patients for postoperative recurrence after permanent ileostomy?. Inflamm Bowel Dis 2012, 18:E196.
64. Cappell M.S. Risks versus benefits of gastrointestinal endoscopy during pregnancy. Nat Rev Gastroenterol Hepatol 2011, 8:610-634.
65. Nikolaus S., Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology 2007, 133:1670-1689.
66. Simpson P., Papadakis K.A. Endoscopic evaluation of patients with inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:1287-1297.
67. Shen B. Endoscopic, imaging and histologic evaluation of Crohn's disease and ulcerative colitis. Am J Gastroenterol 2007, 102:S41-S45.
68. Stange E.F., Travis S.P., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008, 2:1-23.
69. Bousvaros A., Antonioli D.A., Colletti R.B., Dubinsky M.C., Glickman J.N., Gold B.D., et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr 2007, 44:653-674.
70. Ben-Horin S., Margalit M., Bossuyt P., Maul J., Shapira Y., Bojic D., et al. Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection. J Crohns Colitis 2010, 4:194-198.
71. Shanahan F., Targan S., Anton P., Duerr R. Colonoscopy during an attack of severe ulcerative colitis. Am J Gastroenterol 1991, 86:1278.
72. Oberhuber G., Puspok A., Oesterreicher C., Novacek G., Zauner C., Burghuber M., et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 1997, 112:698-706.
73. Sharif F., McDermott M., Dillon M., Drumm B., Rowland M., Imrie C., et al. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis. Am J Gastroenterol 2002, 97:1415-1420.
74. Valdez R., Appelman H.D., Bronner M.P., Greenson J.K. Diffuse duodenitis associated with ulcerative colitis. Am J Surg Pathol 2000, 24:1407-1413.
75. Chutkan R.K., Scherl E., Waye J.D. Colonoscopy in inflammatory bowel disease. Gastrointest Endosc Clin N Am 2002, 12:463-483. [viii].
76. Pera A., Bellando P., Caldera D., Ponti V., Astegiano M., Barletti C., et al. Colonoscopy in inflammatory bowel disease: diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 1987, 92:181-185.
77. Tedesco F.J., Hardin R.D., Harper R.N., Edwards B.H. Infectious colitis endoscopically simulating inflammatory bowel disease: a prospective evaluation. Gastrointest Endosc 1983, 29:195-197.
78. Rameshshanker R., Arebi N. Endoscopy in inflammatory bowel disease when and why. World J Gastrointest Endosc 2012, 4:201-211.
79. Wilcox C.M., Chalasani N., Lazenby A., Schwartz D.A. Cytomegalovirus colitis in acquired immunodeficiency syndrome: a clinical and endoscopic study. Gastrointest Endosc 1998, 48:39-43.
80. Battaglino M.P., Rockey D.C. Cytomegalovirus colitis presenting with the endoscopic appearance of pseudomembranous colitis. Gastrointest Endosc 1999, 50:697-700.
81. Roskell D.E., Hyde G.M., Campbell A.P., Jewell D.P., Gray W. HIV associated cytomegalovirus colitis as a mimic of inflammatory bowel disease. Gut 1995, 37:148-150.
82. Osawa R., Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care 2009, 13:R68.
83. Galiatsatos P., Shrier I., Lamoureux E., Szilagyi A. Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci 2005, 50:609-616.
84. Nishimoto Y., Matsumoto T., Suekane H., Shimizu M., Mikami Y., Iida M. Cytomegalovirus infection in a patient with ulcerative colitis: colonoscopic findings. Gastrointest Endosc 2001, 53:816-818.
85. Ljungman P., Griffiths P., Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002, 34:1094-1097.
86. Kim J.J., Simpson N., Klipfel N., Debose R., Barr N., Laine L. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci 2010, 55:1059-1065.
87. Maconi G., Colombo E., Zerbi P., Sampietro G.M., Fociani P., Bosani M., et al. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis 2005, 37:418-423.
88. Suzuki H., Kato J., Kuriyama M., Hiraoka S., Kuwaki K., Yamamoto K. Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol 2010, 16:1245-1251.
89. Almadi M.A., Ghosh S., Aljebreen A.M. Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am J Gastroenterol 2009, 104:1003-1012.
90. Solem C.A., Loftus E.V., Fletcher J.G., Baron T.H., Gostout C.J., Petersen B.T., et al. Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc 2008, 68:255-266.
91. Jeong S.H., Lee K.J., Kim Y.B., Kwon H.C., Sin S.J., Chung J.Y. Diagnostic value of terminal ileum intubation during colonoscopy. J Gastroenterol Hepatol 2008, 23:51-55.
92. Stahlberg D., Veress B., Tribukait B., Broome U. Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study. Dis Colon Rectum 2003, 46:770-778.
93. Shen B., Wu H., Remzi F., Lopez R., Shen L., Fazio V. Diagnostic value of esophagogastroduodenoscopy in patients with ileal pouch-anal anastomosis. Inflamm Bowel Dis 2009, 15:395-401.
94. Peyrin-Biroulet L., Loftus E.V., Colombel J.F., Sandborn W.J. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010, 105:289-297.
95. Kim K.M., Lee A., Choi K.Y., Lee K.Y., Kwak J.J. Intestinal tuberculosis: clinicopathologic analysis and diagnosis by endoscopic biopsy. Am J Gastroenterol 1998, 93:606-609.
96. Alvares J.F., Devarbhavi H., Makhija P., Rao S., Kottoor R. Clinical, colonoscopic, and histological profile of colonic tuberculosis in a tertiary hospital. Endoscopy 2005, 37:351-356.
97. Gilinsky N.H., Marks I.N., Kottler R.E., Price S.K. Abdominal tuberculosis. A 10-year review. S Afr Med J 1983, 64:849-857.
98. Lee Y.J., Yang S.K., Byeon J.S., Myung S.J., Chang H.S., Hong S.S., et al. Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease. Endoscopy 2006, 38:592-597.
99. Makharia G.K., Srivastava S., Das P., Goswami P., Singh U., Tripathi M., et al. Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis. Am J Gastroenterol 2010, 105:642-651.
100. Epstein D., Watermeyer G., Kirsch R. Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis. Aliment Pharmacol Ther 2007, 25:1373-1388.
101. Pulimood A.B., Amarapurkar D.N., Ghoshal U., Phillip M., Pai C.G., Reddy D.N., et al. Differentiation of Crohn's disease from intestinal tuberculosis in India in 2010. World J Gastroenterol 2011, 17:433-443.
102. Tursi A., Inchingolo C.D., Nenna R., Stoppino G., Zotti M., Panella C., et al. Pattern of mucosal tumor necrosis factor-alpha expression in segmental colitis associated with diverticula suggests a truly autonomous clinical entity. Inflamm Bowel Dis 2008, 14:1315-1317.
103. Mann N.S., Hoda K.K. Segmental colitis associated with diverticulosis: systematic evaluation of 486 cases with meta-analysis. Hepatogastroenterology 2012, 59:2119-2121.
104. Imperiali G., Meucci G., Alvisi C., Fasoli R., Ferrara A., Girelli C.M., et al. Segmental colitis associated with diverticula: a prospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol 2000, 95:1014-1016.
105. Hadithi M., Cazemier M., Meijer G.A., Bloemena E., Felt-Bersma R.J., Mulder C.J., et al. Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World J Gastroenterol 2008, 14:3183-3187.
106. Rispo A., Pasquale L., Cozzolino A., Di Girolamo E., De Palma G.D., Grassia R., et al. Lower prevalence of diverticulosis in patients with ulcerative colitis. Dis Colon Rectum 2007, 50:1164-1168.
107. Lamps L.W., Knapple W.L. Diverticular disease-associated segmental colitis. Clin Gastroenterol Hepatol 2007, 5:27-31.
108. Tursi A., Elisei W., Brandimarte G., Giorgetti G.M., Lecca P.G., Di Cesare L., et al. The endoscopic spectrum of segmental colitis associated with diverticulosis. Colorectal Dis 2010, 12:464-470.
109. Tursi A., Elisei W., Giorgetti G.M., Aiello F., Brandimarte G. Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease. Aliment Pharmacol Ther 2011, 33:358-365.
110. Brandt L.J., Boley S.J. AGA technical review on intestinal ischemia American Gastrointestinal Association. Gastroenterol 2000, 118:954-968.
111. Zou X., Cao J., Yao Y., Liu W., Chen L. Endoscopic findings and clinicopathologic characteristics of ischemic colitis: a report of 85 cases. Dig Dis Sci 2009, 54:2009-2015.
112. Beppu K., Osada T., Nagahara A., Matsumoto K., Shibuya T., Sakamoto N., et al. Relationship between endoscopic findings and clinical severity in ischemic colitis. Intern Med 2011, 50:2263-2267.
113. Habu Y., Tahashi Y., Kiyota K., Matsumura K., Hirota M., Inokuchi H., et al. Reevaluation of clinical features of ischemic colitis. Analysis of 68 consecutive cases diagnosed by early colonoscopy. Scand J Gastroenterol 1996, 31:881-886.
114. Scowcroft C.W., Sanowski R.A., Kozarek R.A. Colonoscopy in ischemic colitis. Gastrointest Endosc 1981, 27:156-161.
115. Mantzaris G.J., Hatzis A., Archavlis E., Petraki K., Lazou A., Ladas S., et al. The role of colonoscopy in the differential diagnosis of acute, severe hemorrhagic colitis. Endoscopy 1995, 27:645-653.
116. Dejaco C., Oesterreicher C., Angelberger S., Puspok A., Birner P., Poetzi R., et al. Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis. Endoscopy 2003, 35:1004-1008.
117. Surawicz C.M., Haggitt R.C., Husseman M., McFarland L.V. Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease. Gastroenterology 1994, 107:755-763.
118. Schumacher G., Sandstedt B., Kollberg B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Clinical findings and early diagnosis. Scand J Gastroenterol 1994, 29:265-274.
119. Schumacher G. First attack of inflammatory bowel disease and infectious colitis. A clinical, histological and microbiological study with special reference to early diagnosis. Scand J Gastroenterol Suppl 1993, 198:1-24.
120. Schumacher G., Kollberg B., Sandstedt B., Jorup C., Grillner L., Ljungh A., et al. A prospective study of first attacks of inflammatory bowel disease and non-relapsing colitis. Microbiologic findings. Scand J Gastroenterol 1993, 28:1077-1085.
121. Surawicz C.M. What's the best way to differentiate infectious colitis (acute self-limited colitis) from IBD?. Inflamm Bowel Dis 2008, 14(Suppl. 2):S157-S158.
122. Nahon S., Bouhnik Y., Lavergne-Slove A., Bitoun A., Panis Y., Valleur P., et al. Colonoscopy accurately predicts the anatomical severity of colonic Crohn's disease attacks: correlation with findings from colectomy specimens. Am J Gastroenterol 2002, 97:3102-3107.
123. Alemayehu G., Jarnerot G. Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making. Am J Gastroenterol 1991, 86:187-190.
124. Higgins P.D., Schwartz M., Mapili J., Zimmermann E.M. Is endoscopy necessary for the measurement of disease activity in ulcerative colitis?. Am J Gastroenterol 2005, 100:355-361.
125. Regueiro M., Rodemann J., Kip K.E., Saul M., Swoger J., Baidoo L., et al. Physician assessment of ulcerative colitis activity correlates poorly with endoscopic disease activity. Inflamm Bowel Dis 2011, 17:1008-1014.
126. Mirpour S., Rabie R., Mirpour K., Gholamrezanezhad A. Evaluation of relationship between clinical and colonoscopic features in patients with active ulcerative colitis. Indian J Gastroenterol 2007, 26:74-76.
127. D'Amato M., Pompili M., Marra G., Rapaccini G.L., Anti M. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel diseases. Gut 1986, 27:1228.
128. Buckell N.A., Williams G.T., Bartram C.I., Lennard-Jones J.E. Depth of ulceration in acute colitis: correlation with outcome and clinical and radiologic features. Gastroenterology 1980, 79:19-25.
129. Hefti M.M., Chessin D.B., Harpaz N.H., Steinhagen R.M., Ullman T.A. Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis. Dis Colon Rectum 2009, 52:193-197.
130. Carbonnel F., Lavergne A., Lemann M., Bitoun A., Valleur P., Hautefeuille P., et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 1994, 39:1550-1557.
131. Seo M., Okada M., Yao T., Matake H., Maeda K. Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index. J Gastroenterol 2002, 37:29-34.
132. Carbonnel F., Gargouri D., Lemann M., Beaugerie L., Cattan S., Cosnes J., et al. Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther 2000, 14:273-279.
133. Bernal I., Manosa M., Domenech E., Garcia-Planella E., Navarro M., Lorenzo-Zuniga V., et al. Predictors of clinical response to systemic steroids in active ulcerative colitis. Dig Dis Sci 2006, 51:1434-1438.
134. Cacheux W., Seksik P., Lemann M., Marteau P., Nion-Larmurier I., Afchain P., et al. Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis. Am J Gastroenterol 2008, 103:637-642.
135. Aratari A., Papi C., Clemente V., Moretti A., Luchetti R., Koch M., et al. Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis 2008, 40:821-826.
136. Navarro-Llavat M., Domenech E., Bernal I., Sanchez-Delgado J., Manterola J.M., Garcia-Planella E., et al. Prospective, observational, cross-sectional study of intestinal infections among acutely active inflammatory bowel disease patients. Digestion 2009, 80:25-29.
137. Rahier J.F., Ben-Horin S., Chowers Y., Conlon C., De Munter P., D'Haens G., et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009, 3:47-91.
138. Rodemann J.F., Dubberke E.R., Reske K.A., Seo da H., Stone C.D. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:339-344.
139. Bossuyt P., Verhaegen J., Van Assche G., Rutgeerts P., Vermeire S. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohns Colitis 2009, 3:4-7.
140. Dignass A., Lindsay J.O., Sturm A., Windsor A., Colombel J.F., Allez M., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis 2012, 6:991-1030.
141. Hueting W.E., Buskens E., van der Tweel I., Gooszen H.G., van Laarhoven C.J. Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients. Dig Surg 2005, 22:69-79.
142. Fazio V.W., Ziv Y., Church J.M., Oakley J.R., Lavery I.C., Milsom J.W., et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995, 222:120-127.
143. McLaughlin S.D., Clark S.K., Thomas-Gibson S., Tekkis P.P., Ciclitira P.J., Nicholls R.J. Guide to endoscopy of the ileo-anal pouch following restorative proctocolectomy with ileal pouch-anal anastomosis; indications, technique, and management of common findings. Inflamm Bowel Dis 2009, 15:1256-1263.
144. Shen B., Fazio V.W., Remzi F.H., Lashner B.A. Clinical approach to diseases of ileal pouch-anal anastomosis. Am J Gastroenterol 2005, 100:2796-2807.
145. Shen B., Fazio V.W., Remzi F.H., Delaney C.P., Bennett A.E., Achkar J.P., et al. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol 2005, 100:93-101.
146. Ghali P., Bitton A. The role of endoscopy in the evaluation of pouches and ostomies. Gastrointest Endosc Clin N Am 2002, 12:605-619.
147. Shen B. Diagnosis and management of postoperative ileal pouch disorders. Clin Colon Rectal Surg 2010, 23:259-268.
148. Shen B., Achkar J.P., Lashner B.A., Ormsby A.H., Remzi F.H., Bevins C.L., et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001, 121:261-267.
149. Moskowitz R.L., Shepherd N.A., Nicholls R.J. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986, 1:167-174.
150. Sandborn W.J., Tremaine W.J., Batts K.P., Pemberton J.H., Phillips S.F. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994, 69:409-415.
151. Shen B., Remzi F.H., Lavery I.C., Lashner B.A., Fazio V.W. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol 2008, 6:145-158. [quiz 124].
152. Shen B. Diagnosis and treatment of patients with pouchitis. Drugs 2003, 63:453-461.
153. Nicholls R.J. Review article: ulcerative colitis-surgical indications and treatment. Aliment Pharmacol Ther 2002, 16(Suppl. 4):25-28.
154. Shen B., Plesec T.P., Remer E., Kiran P., Remzi F.H., Lopez R., et al. Asymmetric endoscopic inflammation of the ileal pouch: a sign of ischemic pouchitis?. Inflamm Bowel Dis 2010, 16:836-846.
155. Moonka D., Furth E.E., MacDermott R.P., Lichtenstein G.R. Pouchitis associated with primary cytomegalovirus infection. Am J Gastroenterol 1998, 93:264-266.
156. Shen B. Crohn's disease of the ileal pouch: reality, diagnosis, and management. Inflamm Bowel Dis 2009, 15:284-294.
157. Shen B., Fazio V.W., Remzi F.H., Delaney C.P., Achkar J.P., Bennett A., et al. Endoscopic balloon dilation of ileal pouch strictures. Am J Gastroenterol 2004, 99:2340-2347.
158. Shen B., Lian L., Kiran R.P., Queener E., Lavery I.C., Fazio V.W., et al. Efficacy and safety of endoscopic treatment of ileal pouch strictures. Inflamm Bowel Dis 2011, 17:2527-2535.
159. Kuiper T., Vlug M.S., van den Broek F.J., Tytgat K.M., van Eeden S., Fockens P., et al. The prevalence of dysplasia in the ileoanal pouch following restorative proctocolectomy for ulcerative colitis with associated dysplasia. Colorectal Dis 2012, 14:469-473.
160. Kariv R., Remzi F.H., Lian L., Bennett A.E., Kiran R.P., Kariv Y., et al. Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy. Gastroenterology 2010, 139:806-812. [812 e801-802].
161. Das P., Johnson M.W., Tekkis P.P., Nicholls R.J. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Colorectal Dis 2007, 9:15-27.
162. Ault G.T., Nunoo-Mensah J.W., Johnson L., Vukasin P., Kaiser A., Beart R.W. Adenocarcinoma arising in the middle of ileoanal pouches: report of five cases. Dis Colon Rectum 2009, 52:538-541.
163. Scarpa M., van Koperen P.J., Ubbink D.T., Hommes D.W., Ten Kate F.J., Bemelman W.A. Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis. Br J Surg 2007, 94:534-545.
164. Herline A.J., Meisinger L.L., Rusin L.C., Roberts P.L., Murray J.J., Coller J.A., et al. Is routine pouch surveillance for dysplasia indicated for ileoanal pouches?. Dis Colon Rectum 2003, 46:156-159.
165. Hernandez J.D., Jimenez-Huyke C., Rosado K., Gonzalez-Keelan C., Lojo J.J., Torres E.A. Surveillance for dysplasia in patients with ileal pouch-anal anastomosis for ulcerative colitis: an interim analysis. Dig Dis Sci 2010, 55:2332-2336.
166. Knupper N., Straub E., Terpe H.J., Vestweber K.H. Adenocarcinoma of the ileoanal pouch for ulcerative colitis-a complication of severe chronic atrophic pouchitis?. Int J Colorectal Dis 2006, 21:478-482.
167. Ozuner G., Fazio V.W., Lavery I.C., Milsom J.W., Strong S.A. Reoperative rates for Crohn's disease following strictureplasty. Long-term analysis. Dis Colon Rectum 1996, 39:1199-1203.
168. Hassan C., Zullo A., De Francesco V., Ierardi E., Giustini M., Pitidis A., et al. Systematic review: endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther 2007, 26:1457-1464.
169. Singh V.V., Draganov P., Valentine J. Efficacy and safety of endoscopic balloon dilation of symptomatic upper and lower gastrointestinal Crohn's disease strictures. J Clin Gastroenterol 2005, 39:284-290.
170. Morini S., Hassan C., Lorenzetti R., Zullo A., Cerro P., Winn S., et al. Long-term outcome of endoscopic pneumatic dilatation in Crohn's disease. Dig Liver Dis 2003, 35:893-897.
171. Stienecker K., Gleichmann D., Neumayer U., Glaser H.J., Tonus C. Long-term results of endoscopic balloon dilatation of lower gastrointestinal tract strictures in Crohn's disease: a prospective study. World J Gastroenterol 2009, 15:2623-2627.
172. Ajlouni Y., Iser J.H., Gibson P.R. Endoscopic balloon dilatation of intestinal strictures in Crohn's disease: safe alternative to surgery. J Gastroenterol Hepatol 2007, 22:486-490.
173. Foster E.N., Quiros J.A., Prindiville T.P. Long-term follow-up of the endoscopic treatment of strictures in pediatric and adult patients with inflammatory bowel disease. J Clin Gastroenterol 2008, 42:880-885.
174. Ferlitsch A., Reinisch W., Puspok A., Dejaco C., Schillinger M., Schofl R., et al. Safety and efficacy of endoscopic balloon dilation for treatment of Crohn's disease strictures. Endoscopy 2006, 38:483-487.
175. Sabate J.M., Villarejo J., Bouhnik Y., Allez M., Gornet J.M., Vahedi K., et al. Hydrostatic balloon dilatation of Crohn's strictures. Aliment Pharmacol Ther 2003, 18:409-413.
176. Breysem Y., Janssens J.F., Coremans G., Vantrappen G., Hendrickx G., Rutgeerts P. Endoscopic balloon dilation of colonic and ileo-colonic Crohn's strictures: long-term results. Gastrointest Endosc 1992, 38:142-147.
177. Williams A.J., Palmer K.R. Endoscopic balloon dilatation as a therapeutic option in the management of intestinal strictures resulting from Crohn's disease. Br J Surg 1991, 78:453-454.
178. Thomas-Gibson S., Brooker J.C., Hayward C.M., Shah S.G., Williams C.B., Saunders B.P. Colonoscopic balloon dilation of Crohn's strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol 2003, 15:485-488.
179. Blomberg B., Rolny P., Jarnerot G. Endoscopic treatment of anastomotic strictures in Crohn's disease. Endoscopy 1991, 23:195-198.
180. Hoffmann J.C., Heller F., Faiss S., von Lampe B., Kroesen A.J., Wahnschaffe U., et al. Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness. Int J Colorectal Dis 2008, 23:689-696.
181. Scimeca D., Mocciaro F., Cottone M., Montalbano L.M., D'Amico G., Olivo M., et al. Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures. Dig Liver Dis 2011, 43:121-125.
182. Mueller T., Rieder B., Bechtner G., Pfeiffer A. The response of Crohn's strictures to endoscopic balloon dilation. Aliment Pharmacol Ther 2010, 31:634-639.
183. Couckuyt H., Gevers A.M., Coremans G., Hiele M., Rutgeerts P. Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn's strictures: a prospective longterm analysis. Gut 1995, 36:577-580.
184. Gevers A.M., Couckuyt H., Coremans G., Hiele M., Rutgeerts P. Efficacy and safety of hydrostatic balloon dilation of ileocolonic Crohn's strictures. A prospective long-term analysis. Acta Gastroenterol Belg 1994, 57:320-322.
185. Nomura E., Takagi S., Kikuchi T., Negoro K., Takahashi S., Kinouchi Y., et al. Efficacy and safety of endoscopic balloon dilation for Crohn's strictures. Dis Colon Rectum 2006, 49:S59-S67.
186. Saunders B.P., Brown G.J., Lemann M., Rutgeerts P. Balloon dilation of ileocolonic strictures in Crohn's disease. Endoscopy 2004, 36:1001-1007.
187. Gustavsson A., Magnuson A., Blomberg B., Andersson M., Halfvarson J., Tysk C. Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn's disease. Aliment Pharmacol Ther 2012, 36:151-158.
188. Van Assche G. Is endoscopic balloon therapy an effective treatment for patients with Crohn's disease strictures?. Nat Clin Pract Gastroenterol Hepatol 2005, 2:298-299.
189. Coffey M.J., Wright R.A. Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn's studies: a prospective longterm analysis. Gastrointest Endosc 1996, 43:89-90.
190. Nguyen-Tang T., Huber O., Gervaz P., Dumonceau J.M. Long-term quality of life after endoscopic dilation of strictured colorectal or colocolonic anastomoses. Surg Endosc 2008, 22:1660-1666.
191. Wibmer A.G., Kroesen A.J., Grone J., Buhr H.J., Ritz J.P. Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn's disease-review of the literature. Int J Colorectal Dis 2010, 25:1149-1157.
192. Kirtley D.W., Willis M., Thomas E. Balloon dilation of recurrent terminal ileal Crohn's stricture. Gastrointest Endosc 1987, 33:399-400.
193. Matsui T., Hatakeyama S., Ikeda K., Yao T., Takenaka K., Sakurai T. Long-term outcome of endoscopic balloon dilation in obstructive gastroduodenal Crohn's disease. Endoscopy 1997, 29:640-645.
194. Kelly S.M., Hunter J.O. Endoscopic balloon dilatation of duodenal strictures in Crohn's disease. Postgrad Med J 1995, 71:623-624.
195. Matsui T., Ikeda K., Tsuda S., Yao K., Sou S., Satoh S., et al. Long-term outcome of endoscopic balloon dilation in obstructive gastrointestinal Crohn's disease: a prospective long-term study. Diagn Ther Endosc 2000, 6:67-75.
196. Thienpont C., D'Hoore A., Vermeire S., Demedts I., Bisschops R., Coremans G., et al. Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy. Gut 2010, 59:320-324.
197. Honzawa Y., Nakase H., Matsuura M., Higuchi H., Toyonaga T., Matsumura K., et al. Prior use of immunomodulatory drugs improves the clinical outcome of endoscopic balloon dilation for intestinal stricture in patients with Crohn's disease. Dig Endosc Jan 29 2013, [Epub ahead of print]. 10.1111/den.12029.
198. Gustavsson A., Magnuson A., Blomberg B., Andersson M., Halfvarson J., Tysk C. Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn's disease. Aliment Pharmacol Ther 2013, 37:430-437.
199. East J.E., Brooker J.C., Rutter M.D., Saunders B.P. A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn's strictures. Clin Gastroenterol Hepatol 2007, 5:1065-1069.
200. Brooker J.C., Beckett C.G., Saunders B.P., Benson M.J. Long-acting steroid injection after endoscopic dilation of anastomotic Crohn's strictures may improve the outcome: a retrospective case series. Endoscopy 2003, 35:333-337.
201. Lavy A. Triamcinolone improves outcome in Crohn's disease strictures. Dis Colon Rectum 1997, 40:184-186.
202. Van Assche G. Intramural steroid injection and endoscopic dilation for Crohn's disease. Clin Gastroenterol Hepatol 2007, 5:1027-1028.
203. Di Nardo G., Oliva S., Passariello M., Pallotta N., Civitelli F., Frediani S., et al. Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn's disease with stricture: a prospective, randomized, double-blind, controlled trial. Gastrointest Endosc 2010, 72:1201-1208.
204. Swaminath A., Lichtiger S. Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohn's colitis. Inflamm Bowel Dis 2008, 14:213-216.
205. Pohl J., May A., Nachbar L., Ell C. Diagnostic and therapeutic yield of push-and-pull enteroscopy for symptomatic small bowel Crohn's disease strictures. Eur J Gastroenterol Hepatol 2007, 19:529-534.
206. Fukumoto A., Tanaka S., Yamamoto H., Yao T., Matsui T., Iida M., et al. Diagnosis and treatment of small-bowel stricture by double balloon endoscopy. Gastrointest Endosc 2007, 66:S108-S112.
207. Hirai F., Beppu T., Sou S., Seki T., Yao K., Matsui T. Endoscopic balloon dilatation using double-balloon endoscopy is a useful and safe treatment for small intestinal strictures in Crohn's disease. Dig Endosc 2010, 22:200-204.
208. Perez-Cuadrado E., Molina Perez E. Multiple strictures in jejunal Crohn's disease: push enteroscopy dilation. Endoscopy 2001, 33:194.
209. Matsuhashi N., Nakajima A., Suzuki A., Yazaki Y., Takazoe M. Long-term outcome of non-surgical strictureplasty using metallic stents for intestinal strictures in Crohn's disease. Gastrointest Endosc 2000, 51:343-345.
210. Loras C., Perez-Roldan F., Gornals J.B., Barrio J., Igea F., Gonzalez-Huix F., et al. Endoscopic treatment with self-expanding metal stents for Crohn's disease strictures. Aliment Pharmacol Ther 2012, 36:833-839.
211. Truelove S.C., Witts L.J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955, 2:1041-1048.
212. Baron J.H., Connell A.M., Lennard-Jones J.E. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964, 1:89-92.
213. Powell-Tuck J., Bown R.L., Lennard-Jones J.E. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978, 13:833-837.
214. Sutherland L.R., Martin F., Greer S., Robinson M., Greenberger N., Saibil F., et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987, 92:1894-1898.
215. Schroeder K.W., Tremaine W.J., Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987, 317:1625-1629.
216. Rutgeerts P., Sandborn W.J., Feagan B.G., Reinisch W., Olson A., Johanns J., et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005, 353:2462-2476.
217. Van Assche G., Sandborn W.J., Feagan B.G., Salzberg B.A., Silvers D., Monroe P.S., et al. Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial. Gut 2006, 55:1568-1574.
218. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989, 298:82-86.
219. Samuel S., Bruining D.H., Loftus E.V., Thia K.T., Schroeder K.W., Tremaine W.J., et al. Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. Clin Gastroenterol Hepatol 2013, 11(49-54):e41.
220. Marteau P., Lemann M., Seksik P., Laharie D., Colombel J.F., Bouhnik Y., et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 2006, 55:842-847.
221. Calabrese E., Petruzziello C., Onali S., Condino G., Zorzi F., Pallone F., et al. Severity of postoperative recurrence in Crohn's disease: correlation between endoscopic and sonographic findings. Inflamm Bowel Dis 2009, 15:1635-1642.
222. Hanauer S.B., Korelitz B.I., Rutgeerts P., Peppercorn M.A., Thisted R.A., Cohen R.D., et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004, 127:723-729.
223. Reinisch W., Angelberger S., Petritsch W., Shonova O., Lukas M., Bar-Meir S., et al. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut 2010, 59:752-759.
224. Sailer J., Peloschek P., Reinisch W., Vogelsang H., Turetschek K., Schima W. Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol 2008, 18:2512-2521.
225. Mary J.Y., Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989, 30:983-989.
226. Daperno M., D'Haens G., Van Assche G., Baert F., Bulois P., Maunoury V., et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004, 60:505-512.
227. Cellier C., Sahmoud T., Froguel E., Adenis A., Belaiche J., Bretagne J.F., et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 1994, 35:231-235.
228. Modigliani R., Mary J.Y., Simon J.F., Cortot A., Soule J.C., Gendre J.P., et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990, 98:811-818.
229. Allez M., Lemann M., Bonnet J., Cattan P., Jian R., Modigliani R. Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy. Am J Gastroenterol 2002, 97:947-953.
230. Colombel J.F., Hebuterne X. Endoscopic mucosal improvement in patients with active Crohn's disease treated with certolizumab Pegol: first results of the MUSIC clinical trial. Am J Gastroenterol 2008, 103:1107 (A).
231. Louis E., Mary J.Y., Vernier-Massouille G., Grimaud J.C., Bouhnik Y., Laharie D., et al. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology 2012, 142(63-70):e65. (quiz e31).
232. Reinisch W., Rutgeerts P., Panaccione R., D'Haens G., Thakkar R., Yu A. Identifying appropriate dichotomizing points for SES-CD to predict long-term clinical remission for adalimumab-treated patients with Crohn's disease. J Crohns Colitis 2010, 4:P045.
233. Baert F., Moortgat L., Van Assche G., Caenepeel P., Vergauwe P., De Vos M., et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010, 138:463-468. [quiz e410-461].
234. Daperno M., Castiglione F., de Ridder L., Dotan I., Farkkila M., Florholmen J., et al. Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease. J Crohns Colitis 2011, 5:484-498.
235. Froslie K.F., Jahnsen J., Moum B.A., Vatn M.H. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007, 133:412-422.
236. Ardizzone S., Cassinotti A., Duca P., Mazzali C., Penati C., Manes G., et al. Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis. Clin Gastroenterol Hepatol 2011, 9(483-489):e483.
237. Rutter M.D., Saunders B.P., Wilkinson K.H., Rumbles S., Schofield G., Kamm M.A., et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004, 53:1813-1816.
238. Wright R., Truelove S.R. Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets. Am J Dig Dis 1966, 11:847-857.
239. Rutter M., Saunders B., Wilkinson K., Rumbles S., Schofield G., Kamm M., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004, 126:451-459.
240. Zahn A., Hinz U., Karner M., Ehehalt R., Stremmel W. Health-related quality of life correlates with clinical and endoscopic activity indexes but not with demographic features in patients with ulcerative colitis. Inflamm Bowel Dis 2006, 12:1058-1067.
241. Feagan B.G., Reinisch W., Rutgeerts P., Sandborn W.J., Yan S., Eisenberg D., et al. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am J Gastroenterol 2007, 102:794-802.
242. Nishio Y., Ando T., Maeda O., Ishiguro K., Watanabe O., Ohmiya N., et al. Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis. Gut 2006, 55:1768-1773.
243. Kiesslich R., Duckworth C.A., Moussata D., Gloeckner A., Lim L.G., Goetz M., et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 2012, 61:1146-1153.
244. Solberg I.C., Lygren I., Jahnsen J., Aadland E., Hoie O., Cvancarova M., et al. Clinical course during the first 10years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009, 44:431-440.
245. Solberg I.C., Lygren I., Jahnsen J., Vatn M., Moum B. Mucosal healing after initial treatment may be a prognostic marker for long-term outcome in inflammatory bowel disease. Gut 2008, 57:A15.
246. D'Haens G.R., Noman M., Baert F., et al. Endoscopic healing after infliximab treatment for Crohn's disease provides a longer time to relapse. Gastroenterology 2002, 122:A100.
247. Hanauer S.B., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002, 359:1541-1549.
248. Rutgeerts P., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004, 126:402-413.
249. Colombel J.F., Sandborn W.J., Reinisch W., Mantzaris G.J., Kornbluth A., Rachmilewitz D., et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010, 362:1383-1395.
250. Reinisch W., Rutgeerts P.J., Colombel J.F., et al. Association of steroid-free clinical remission and complete mucosal healing at 6months with clinical outcome at 1year: a post-hoc analysis of SONIC trial data. Gastroenterology 2011, 140:S261-S262.
251. Colombel J.F., Rutgeerts P., Sandborn W.J., et al. Achievement of early deep remission predicts better long-term outcomes for adalimumab-treated patients with Crohn's disease: data from EXTEND. Am J Gastroenterol 2010, 105:S434-S435.
252. D'Haens G., Baert F., van Assche G., Caenepeel P., Vergauwe P., Tuynman H., et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 2008, 371:660-667.
253. Schnitzler F., Fidder H., Ferrante M., Noman M., Arijs I., Van Assche G., et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 2009, 15:1295-1301.
254. Mary J.Y., Lemann M., Colombel J.F., et al. Endoscopic remission and response in Crohn's disease: an objective definition using the CDEIS. Gut 2005, 54:A50.
255. Ferrante M., Colombel J.F., Sandborn W.J., et al. Evolution of endoscopic activity scores in patients with Crohn's disease under azathioprine and/or infliximab: a post-hoc analysis of the SONIC data. Gastroenterology 2011, 140:S422.
256. Lemann M., Mary J.Y., Colombel J.F., Duclos B., Soule J.C., Lerebours E., et al. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology 2005, 128:1812-1818.
257. Dionisio P.M., Gurudu S.R., Leighton J.A., Leontiadis G.I., Fleischer D.E., Hara A.K., et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn's disease: a meta-analysis. Am J Gastroenterol 2010, 105:1240-1248. [quiz 1249].
258. Jensen M.D., Nathan T., Rafaelsen S.R., Kjeldsen J. Diagnostic accuracy of capsule endoscopy for small bowel Crohn's disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol Hepatol 2011, 9:124-129.
259. Toth E., Nemeth A., Nielsen J., Wurm Johansson G., Ekberg O., Thorlacius H. Capsule endoscopy is superior to magnetic resonance enterography for detection of Crohn's lesions in the small bowel. Gut 2011, 60:A404.
260. Pica R., Cassieri C., Avallone E.V., Crispino P., Rivera M., Paoluzi P. Small bowel involvement in Crohn's disease: a prospective study comparing wireless capsule endoscopy and magnetic resonance enteroclysis. Gut 2012, 61:A398.
261. Pineton de Chambrun G., Peyrin-Biroulet L., Lemann M., Colombel J.F. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol 2010, 7:15-29.
262. Lewis B.S., Eisen G.M., Friedman S. A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy 2005, 37:960-965.
263. Leighton J.A. The role of endoscopic imaging of the small bowel in clinical practice. Am J Gastroenterol 2011, 106:27-36. [quiz 37].
264. Mehdizadeh S., Chen G.C., Barkodar L., Enayati P.J., Pirouz S., Yadegari M., et al. Capsule endoscopy in patients with Crohn's disease: diagnostic yield and safety. Gastrointest Endosc 2010, 71:121-127.
265. Doherty G.A., Moss A.C., Cheifetz A.S. Capsule endoscopy for small-bowel evaluation in Crohn's disease. Gastrointest Endosc 2011, 74:167-175.
266. Levesque B.G. Yield to diagnostic accuracy: capsule endoscopy in Crohn's disease. Gastrointest Endosc 2010, 71:128-130.
267. Maiden L., Thjodleifsson B., Seigal A., Bjarnason I.I., Scott D., Birgisson S., et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol 2007, 5:1040-1045.
268. Graham D.Y., Opekun A.R., Willingham F.F., Qureshi W.A. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005, 3:55-59.
269. Goldstein J.L., Eisen G.M., Lewis B., Gralnek I.M., Zlotnick S., Fort J.G. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005, 3:133-141.
270. Maiden L., Thjodleifsson B., Theodors A., Gonzalez J., Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005, 128:1172-1178.
271. Lewis J.R., Pashinsky Y., Tinsley A., Lewis B.S. Capsule endoscopy in healthy individuals. Gastroenterology 2012, 142:S-52-S-53.
272. Tukey M., Pleskow D., Legnani P., Cheifetz A.S., Moss A.C. The utility of capsule endoscopy in patients with suspected Crohn's disease. Am J Gastroenterol 2009, 104:2734-2739.
273. Shim K.N., Kim Y.S., Kim K.J., Kim Y.H., Kim T.I., Do J.H., et al. Abdominal pain accompanied by weight loss may increase the diagnostic yield of capsule endoscopy: a Korean multicenter study. Scand J Gastroenterol 2006, 41:983-988.
274. Adler S.N., Yoav M., Eitan S., Yehuda C., Eliakim R. Does capsule endoscopy have an added value in patients with perianal disease and a negative work up for Crohn's disease?. World J Gastrointest Endosc 2012, 4:185-188.
275. De Bona M., Bellumat A., Cian E., Valiante F., Moschini A., De Boni M. Capsule endoscopy findings in patients with suspected Crohn's disease and biochemical markers of inflammation. Dig Liver Dis 2006, 38:331-335.
276. Valle J., Alcantara M., Perez-Grueso M.J., Navajas J., Munoz-Rosas C., Legaz M.L., et al. Clinical features of patients with negative results from traditional diagnostic work-up and Crohn's disease findings from capsule endoscopy. J Clin Gastroenterol 2006, 40:692-696.
277. Rosa B., Moreira M.J., Rodrigues S., Cardoso H., Rebelo A., Marques M., et al. Lewis Score and capsule endoscopy findings in Crohn's disease. Gut 2011, 60:A402.
278. Rodrigues S., Magro F., Cardoso H., Rosa B., Moreira M.J., Marques M., et al. Role of capsule endoscopy in the evaluation of different segments of the small bowel in Crohn's disease: correlation of biomarkers, endoscopy, and Lewis score. Endoscopy 2011, 43:A130.
279. Sipponen T., Haapamaki J., Savilahti E., Alfthan H., Hamalainen E., Rautiainen H., et al. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy. Scand J Gastroenterol 2012, 47:778-784.
280. Koulaouzidis A., Douglas S., Rogers M.A., Arnott I.D., Plevris J.N. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy. Scand J Gastroenterol 2011, 46:561-566.
281. Aggarwal V., Day A.S., Connor S.J., Leach S.T., Grimm M.C., Craig P.I. Capsule endoscopy findings in small bowel Crohn's disease patients in clinical remission: correlation with the Crohn's disease activity index, faecal calprotectin and S100A12. Gastroenterology 2010, 138:S114:S114.
282. Koulaouzidis A., Douglas S., Plevris J.N. Lewis score correlates more closely with fecal calprotectin than Capsule Endoscopy Crohn's Disease Activity Index. Dig Dis Sci 2012, 57:987-993.
283. May A., Manner H., Schneider M., Ipsen A., Ell C. Prospective multicenter trial of capsule endoscopy in patients with chronic abdominal pain, diarrhea and other signs and symptoms (CEDAP-Plus Study). Endoscopy 2007, 39:606-612.
284. Bardan E., Nadler M., Chowers Y., Fidder H., Bar-Meir S. Capsule endoscopy for the evaluation of patients with chronic abdominal pain. Endoscopy 2003, 35:688-689.
285. Viazis N., Zacharakis G., Saprikis E., Anastasopoulos H., Kechagias G., Markoutsaki T., et al. A single center experience of 2300 consecutive patients undergoing capsule endoscopy: indications and diagnostic yield. Endoscopy 2011, 43:A129.
286. Mergener K., Ponchon T., Gralnek I., Pennazio M., Gay G., Selby W., et al. Literature review and recommendations for clinical application of small-bowel capsule endoscopy, based on a panel discussion by international experts. Consensus statements for small-bowel capsule endoscopy, 2006/2007. Endoscopy 2007, 39:895-909.
287. Rosa B., Moreira M.J., Rebelo A., Cotter J. Lewis Score: a useful clinical tool for patients with suspected Crohn's Disease submitted to capsule endoscopy. J Crohns Colitis 2012, 6:692-697.
288. Voderholzer W.A., Beinhoelzl J., Rogalla P., Murrer S., Schachschal G., Lochs H., et al. Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut 2005, 54:369-373.
289. Petruzziello C., Onali S., Calabrese E., Zorzi F., Ascolani M., Condino G., et al. Wireless capsule endoscopy and proximal small bowel lesions in Crohn's disease. World J Gastroenterol 2010, 16:3299-3304.
290. Niv Y. Diagnostic value of capsule endoscopy during relapse in co-morbid irritable bowel syndrome and Crohn's disease. Eur J Gastroenterol Hepatol 2004, 16:1073-1074.
291. Leighton J.A., Triester S.L., Sharma V.K. Capsule endoscopy: a meta-analysis for use with obscure gastrointestinal bleeding and Crohn's disease. Gastrointest Endosc Clin N Am 2006, 16:229-250.
292. Pons Beltran V., Nos P., Bastida G., Beltran B., Arguello L., Aguas M., et al. Evaluation of postsurgical recurrence in Crohn's disease: a new indication for capsule endoscopy?. Gastrointest Endosc 2007, 66:533-540.
293. Bourreille A., Jarry M., D'Halluin P.N., Ben-Soussan E., Maunoury V., Bulois P., et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: a prospective study. Gut 2006, 55:978-983.
294. Efthymiou A., Viazis N., Mantzaris G., Papadimitriou N., Tzourmakliotis D., Raptis S., et al. Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy. Inflamm Bowel Dis 2008, 14:1542-1547.
295. Lewis B.S. Expanding role of capsule endoscopy in inflammatory bowel disease. World J Gastroenterol 2008, 14:4137-4141.
296. Niv Y., Ilani S., Levi Z., Hershkowitz M., Niv E., Fireman Z., et al. Validation of the Capsule Endoscopy Crohn's Disease Activity Index (CECDAI or Niv score): a multicenter prospective study. Endoscopy 2012, 44:21-26.
297. Castro F.D., Rosa B., Moreira M.J., Cotter J. Impact of capsule endoscopy on management of Crohn's disease: a single center experience. Gastrointest Endosc 2012, 75:AB254.
298. Long M.D., Barnes E., Isaacs K., Morgan D., Herfarth H.H. Impact of capsule endoscopy on management of inflammatory bowel disease: a single tertiary care center experience. Inflamm Bowel Dis 2011, 17:1855-1862.
299. Lorenzo-Zuniga V., de Vega V.M., Domenech E., Cabre E., Manosa M., Boix J. Impact of capsule endoscopy findings in the management of Crohn's Disease. Dig Dis Sci 2010, 55:411-414.
300. Sidhu R., McAlindon M.E., Drew K., Hardcastle S., Cameron I.C., Sanders D.S. Evaluating the role of small-bowel endoscopy in clinical practice: the largest single-centre experience. Eur J Gastroenterol Hepatol 2012, 24:513-519.
301. Gurudu S.R., Leighton J.A. Correlation of two capsule endoscopy scoring systems with fecal calprotectin: does it really matter?. Dig Dis Sci 2012, 57:827-829.
302. Mow W.S., Lo S.K., Targan S.R., Dubinsky M.C., Treyzon L., Abreu-Martin M.T., et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol 2004, 2:31-40.
303. Jensen M.D., Nathan T., Kjeldsen J. Inter-observer agreement for detection of small bowel Crohn's disease with capsule endoscopy. Scand J Gastroenterol 2010, 45:878-884.
304. Gal E., Geller A., Fraser G., Levi Z., Niv Y. Assessment and validation of the new capsule endoscopy Crohn's disease activity index (CECDAI). Dig Dis Sci 2008, 53:1933-1937.
305. Gralnek I.M., Defranchis R., Seidman E., Leighton J.A., Legnani P., Lewis B.S. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008, 27:146-154.
306. Swaminath A., Legnani P., Kornbluth A. Video capsule endoscopy in inflammatory bowel disease: past, present, and future redux. Inflamm Bowel Dis 2010, 16:1254-1262.
307. Vind I., Riis L., Jess T., Knudsen E., Pedersen N., Elkjaer M., et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006, 101:1274-1282.
308. Stewenius J., Adnerhill I., Ekelund G., Floren C.H., Fork F.T., Janzon L., et al. Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden. A 25-year incidence study. Scand J Gastroenterol 1995, 30:38-43.
309. Maunoury V., Savoye G., Bourreille A., Bouhnik Y., Jarry M., Sacher-Huvelin S., et al. Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified). Inflamm Bowel Dis 2007, 13:152-155.
310. Mehdizadeh S., Chen G., Enayati P.J., Cheng D.W., Han N.J., Shaye O.A., et al. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU). Endoscopy 2008, 40:30-35.
311. Di Nardo G., Oliva S., Ferrari F., Riccioni M.E., Staiano A., Lombardi G., et al. Usefulness of wireless capsule endoscopy in paediatric inflammatory bowel disease. Dig Liver Dis 2011, 43:220-224.
312. Joossens S., Reinisch W., Vermeire S., Sendid B., Poulain D., Peeters M., et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 2002, 122:1242-1247.
313. Shen B., Remzi F.H., Santisi J., Lashner B.A., Brzezinski A., Fazio V.W. Application of wireless capsule endoscopy for the evaluation of iron deficiency anemia in patients with ileal pouches. J Clin Gastroenterol 2008, 42:897-902.
314. Murrell Z., Vasiliauskas E., Melmed G., Lo S., Targan S., Fleshner P. Preoperative wireless capsule endoscopy does not predict outcome after ileal pouch-anal anastomosis. Dis Colon Rectum 2010, 53:293-300.
315. Schluender S.J., Mehdizadeh S., Vasiliaukas E.A., Dubinsky M., Papadakis K.A., Ippoliti A., et al. Does preoperative wireless endoscopic capsule predict long-term outcome after ileal pouch-anal anastomosis (IPAA)?. Gastroenterology 2006, 130.
316. Meister T., Heinzow H., Dortgolz A., Lenze F., Ross M., Domagk D., et al. Colon capsule endoscopy versus standard colonoscopy in assessing disease activity in patients with ulcerative colitis: a prospective trial. Gastrointest Endosc 2012, 75:AB475.
317. Sung J., Ho K.Y., Chiu H.M., Ching J., Travis S., Peled R. The use of Pillcam Colon in assessing mucosal inflammation in ulcerative colitis: a multicenter study. Endoscopy 2012, 44:754-758.
318. Postgate A.J., Burling D., Gupta A., Fitzpatrick A., Fraser C. Safety, reliability and limitations of the given patency capsule in patients at risk of capsule retention: a 3-year technical review. Dig Dis Sci 2008, 53:2732-2738.
319. Cheifetz A.S., Kornbluth A.A., Legnani P., Schmelkin I., Brown A., Lichtiger S., et al. The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease. Am J Gastroenterol 2006, 101:2218-2222.
320. Liao Z., Gao R., Xu C., Li Z.S. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review. Gastrointest Endosc 2010, 71:280-286.
321. Hoog C.M., Bark L.A., Arkani J., Gorsetman J., Brostrom O., Sjoqvist U. Capsule retentions and incomplete capsule endoscopy examinations: an analysis of 2300 examinations. Gastroenterol Res Pract 2012, 2012:518718.
322. Levesque B.G., Cipriano L.E., Chang S.L., Lee K.K., Owens D.K., Garber A.M. Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease. Clin Gastroenterol Hepatol 2010, 8:261-267. [267 e261-264].
323. Leighton J.A., Gralnek I.M., Richner R.E., Lacey M.J., Papatheofanis F.J. Capsule endoscopy in suspected small bowel Crohn's disease: economic impact of disease diagnosis and treatment. World J Gastroenterol 2009, 15:5685-5692.
324. Rondonotti E., Soncini M., Girelli C., Ballardini G., Bianchi G., Brunati S., et al. Small bowel capsule endoscopy in clinical practice: a multicenter 7-year survey. Eur J Gastroenterol Hepatol 2010, 22:1380-1386.
325. Herrerias J.M., Leighton J.A., Costamagna G., Infantolino A., Eliakim R., Fischer D., et al. Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopy. Gastrointest Endosc 2008, 67:902-909.
326. Yadav A., Heigh R.I., Hara A.K., Decker G.A., Crowell M.D., Gurudu S.R., et al. Performance of the patency capsule compared with nonenteroclysis radiologic examinations in patients with known or suspected intestinal strictures. Gastrointest Endosc 2011, 74:834-839.
327. Tanaka S., Mitsui K., Shirakawa K., Tatsuguchi A., Nakamura T., Hayashi Y., et al. Successful retrieval of video capsule endoscopy retained at ileal stenosis of Crohn's disease using double-balloon endoscopy. J Gastroenterol Hepatol 2006, 21:922-923.
328. Van Weyenberg S.J., Van Turenhout S.T., Bouma G., Van Waesberghe J.H., Van der Peet D.L., Mulder C.J., et al. Double-balloon endoscopy as the primary method for small-bowel video capsule endoscope retrieval. Gastrointest Endosc 2010, 71:535-541.
329. Bai Y., Gao J., Song B., Zhou Y.Q., Zou D.W., Li Z.S. Surgical intervention for capsule endoscope retained at ileal stricture. Endoscopy 2007, 39(Suppl. 1):E268-E269.
330. Magdeburg R., Riester T., Hummel F., Lohr M., Post S., Sturm J. Ileus secondary to wireless capsule enteroscopy. Int J Colorectal Dis 2006, 21:610-613.
331. Vernier-Massouille G., Balde M., Salleron J., Turck D., Dupas J.L., Mouterde O., et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008, 135:1106-1113.
332. Cosnes J., Gower-Rousseau C., Seksik P., Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011, 140:1785-1794.
333. de Ridder L., Mensink P.B., Lequin M.H., Aktas H., de Krijger R.R., van der Woude C.J., et al. Single-balloon enteroscopy, magnetic resonance enterography, and abdominal US useful for evaluation of small-bowel disease in children with (suspected) Crohn's disease. Gastrointest Endosc 2012, 75:87-94.
334. Mensink P.B., Groenen M.J., van Buuren H.R., Kuipers E.J., van der Woude C.J. Double-balloon enteroscopy in Crohn's disease patients suspected of small bowel activity: findings and clinical impact. J Gastroenterol 2009, 44:271-276.
335. Mensink P.B., Aktas H., Zelinkova Z., West R.L., Kuipers E.J., van der Woude C.J. Impact of double-balloon enteroscopy findings on the management of Crohn's disease. Scand J Gastroenterol 2010, 45:483-489.
336. Heine G.D., Hadithi M., Groenen M.J., Kuipers E.J., Jacobs M.A., Mulder C.J. Double-balloon enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients with suspected small-bowel disease. Endoscopy 2006, 38:42-48.
337. Gay G., Delvaux M. Double balloon enteroscopy in Crohn's disease and related disorders: our experience. Gastrointest Endosc 2007, 66:S82-S90.
338. Manes G., Imbesi V., Ardizzone S., Cassinotti A., Pallotta S., Porro G.B. Use of double-balloon enteroscopy in the management of patients with Crohn's disease: feasibility and diagnostic yield in a high-volume centre for inflammatory bowel disease. Surg Endosc 2009, 23:2790-2795.
339. Wiarda B.M., Heine D.G., Mensink P., Stolk M., Dees J., Hazenberg H.J., et al. Comparison of magnetic resonance enteroclysis and capsule endoscopy with balloon-assisted enteroscopy in patients with obscure gastrointestinal bleeding. Endoscopy 2012, 44:668-673.
340. Seiderer J., Herrmann K., Diepolder H., Schoenberg S.O., Wagner A.C., Goke B., et al. Double-balloon enteroscopy versus magnetic resonance enteroclysis in diagnosing suspected small-bowel Crohn's disease: results of a pilot study. Scand J Gastroenterol 2007, 42:1376-1385.
341. Di Nardo G., Oliva S., Aloi M., Rossi P., Casciani E., Masselli G., et al. Usefulness of single-balloon enteroscopy in pediatric Crohn's disease. Gastrointest Endosc 2012, 75:80-86.
342. Despott E.J., Gupta A., Burling D., Tripoli E., Konieczko K., Hart A., et al. Effective dilation of small-bowel strictures by double-balloon enteroscopy in patients with symptomatic Crohn's disease (with video). Gastrointest Endosc 2009, 70:1030-1036.
343. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
344. Ekbom A., Helmick C., Zack M., Adami H.O. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990, 323:1228-1233.
345. Soderlund S., Brandt L., Lapidus A., Karlen P., Brostrom O., Lofberg R., et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 2009, 136:1561-1567.
346. Bernstein C.N., Blanchard J.F., Kliewer E., Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001, 91:854-862.
347. Winther K.V., Jess T., Langholz E., Munkholm P., Binder V. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2004, 2:1088-1095.
348. Jess T., Loftus E.V., Velayos F.S., Harmsen W.S., Zinsmeister A.R., Smyrk T.C., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county Minnesota. Gastroenterology 2006, 130:1039-1046.
349. Jess T., Rungoe C., Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012, 10:639-645.
350. Loftus E.V. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis. Gastroenterol Clin North Am 2006, 35:517-531.
351. Friedman S., Rubin P.H., Bodian C., Harpaz N., Present D.H. Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25years. Clin Gastroenterol Hepatol 2008, 6:993-998.
352. Gillen C.D., Walmsley R.S., Prior P., Andrews H.A., Allan R.N. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994, 35:1590-1592. [see comments].
353. Ekbom A., Helmick C., Zack M., Adami H.O. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990, 336:357-359.
354. Collins P.D., Mpofu C., Watson A.J., Rhodes J.M. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006, CD000279.
355. Palli D., Trallori G., Saieva C., Tarantino O., Edili E., d'Albasio G., et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study. Gut 1998, 42:175-179.
356. Lakatos L., Mester G., Erdelyi Z., David G., Pandur T., Balogh M., et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 2006, 12:205-211.
357. Jess T., Loftus E.V., Velayos F.S., Winther K.V., Tremaine W.J., Zinsmeister A.R., et al. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota. Am J Gastroenterol 2007, 102:829-836.
358. Rutter M.D., Saunders B.P., Wilkinson K.H., Rumbles S., Schofield G., Kamm M.A., et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006, 130:1030-1038.
359. Lutgens M.W., Vleggaar F.P., Schipper M.E., Stokkers P.C., van der W.J., Hommes D.W., et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut 2008, 57:1246-1251.
360. Lennard-Jones J.E., Melville D.M., Morson B.C., Ritchie J.K., Williams C.B. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22years. Gut 1990, 31:800-806.
361. Itzkowitz S.H., Present D.H. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:314-321.
362. Gupta R.B., Harpaz N., Itzkowitz S., Hossain S., Matula S., Kornbluth A., et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007, 133:1099-1105.
363. Velayos F.S., Loftus E.V., Jess T., Harmsen W.S., Bida J., Zinsmeister A.R., et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology 2006, 130:1941-1949.
364. Soetikno R.M., Lin O.S., Heidenreich P.A., Young H.S., Blackstone M.O. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 2002, 56:48-54.
365. Nuako K.W., Ahlquist D.A., Mahoney D.W., Schaid D.J., Siems D.M., Lindor N.M. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 1998, 115:1079-1083.
366. Askling J., Dickman P.W., Karlen P., Brostrom O., Lapidus A., Lofberg R., et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001, 120:1356-1362.
367. Jess T., Simonsen J., Jorgensen K.T., Pedersen B.V., Nielsen N.M., Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30years. Gastroenterology 2012, 143:375-381. [e371; quiz e313-374].
368. Greenstein A.J., Sachar D.B., Smith H., Pucillo A., Papatestas A.E., Kreel I., et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979, 77:290-294.
369. Karvellas C.J., Fedorak R.N., Hanson J., Wong C.K. Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40years of age. Can J Gastroenterol 2007, 21:443-446.
370. Lashner B.A., Kane S.V., Hanauer S.B. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 1990, 85:1083-1087.
371. Choi P.M., Nugent F.W., Schoetz D.J., Silverman M.L., Haggitt R.C. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993, 105:418-424.
372. Lutgens M.W., Oldenburg B., Siersema P.D., van Bodegraven A.A., Dijkstra G., Hommes D.W., et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer 2009, 101:1671-1675.
373. Karlen P., Kornfeld D., Brostrom O., Lofberg R., Persson P.G., Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998, 42:711-714.
374. Eaden J., Abrams K., Ekbom A., Jackson E., Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000, 14:145-153.
375. Provenzale D., Wong J.B., Onken J.E., Lipscomb J. Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. Am J Gastroenterol 1998, 93:872-880.
376. Van Assche G., Dignass A., Bokemeyer B., Danese S., Gionchetti P., Moser G., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013, 7:1-33.
377. Cairns S.R., Scholefield J.H., Steele R.J., Dunlop M.G., Thomas H.J., Evans G.D., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010, 59:666-689.
378. Bernstein C.N., Shanahan F., Weinstein W.M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?. Lancet 1994, 343:71-74.
379. Jess T., Loftus E.V., Velayos F.S., Harmsen W.S., Zinsmeister A.R., Smyrk T.C., et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County Minnesota. Inflamm Bowel Dis 2006, 12:669-676.
380. Befrits R., Ljung T., Jaramillo E., Rubio C. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum 2002, 45:615-620.
381. Leidenius M., Kellokumpu I., Husa A., Riihela M., Sipponen P. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut 1991, 32:1521-1525.
382. Rutegard J., Ahsgren L., Stenling R., Janunger K.G. Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol 1988, 23:139-145.
383. Lim C.H., Dixon M.F., Vail A., Forman D., Lynch D.A., Axon A.T. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 2003, 52:1127-1132.
384. Thomas T., Abrams K.A., Robinson R.J., Mayberry J.F. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007, 25:657-668.
385. Connell W.R., Lennard-Jones J.E., Williams C.B., Talbot I.C., Price A.B., Wilkinson K.H. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994, 107:934-944.
386. Subramanian V., Ramappa V., Telakis E., Mannath J., Jawhari A.U., Hawkey C.J., et al. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis 2012, 19:350-355.
387. Barclay R.L., Vicari J.J., Doughty A.S., Johanson J.F., Greenlaw R.L. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006, 355:2533-2541.
388. Toruner M., Harewood G.C., Loftus E.V., Sandborn W.J., Tremaine W.J., Faubion W.A., et al. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:428-434.
389. Kiesslich R., Fritsch J., Holtmann M., Koehler H.H., Stolte M., Kanzler S., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003, 124:880-888.
390. Hurlstone D.P., Sanders D.S., Lobo A.J., McAlindon M.E., Cross S.S. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005, 37:1186-1192.
391. Kiesslich R., Goetz M., Lammersdorf K., Schneider C., Burg J., Stolte M., et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007, 132:874-882.
392. Marion J.F., Waye J.D., Present D.H., Israel Y., Bodian C., Harpaz N., et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008, 103:2342-2349.
393. Matsumoto T., Nakamura S., Jo Y., Yao T., Iida M. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol 2003, 98:1827-1833.
394. Rutter M.D., Saunders B.P., Schofield G., Forbes A., Price A.B., Talbot I.C. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004, 53:256-260.
395. Hlavaty T., Huorka M., Koller T., Zita P., Kresanova E., Rychly B., et al. Colorectal cancer screening in patients with ulcerative and Crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy. Eur J Gastroenterol Hepatol 2011, 23:680-689.
396. van den Broek F.J., Stokkers P.C., Reitsma J.B., Boltjes R.P., Ponsioen C.Y., Fockens P., et al. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences. Am J Gastroenterol Mar 22 2011, [Epub ahead of print].
397. Subramanian V., Mannath J., Ragunath K., Hawkey C.J. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011, 33:304-312.
398. Wu L., Li P., Wu J., Cao Y., Gao F. The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials. Colorectal Dis 2012, 14:416-420.
399. Dekker E., van den Broek F.J., Reitsma J.B., Hardwick J.C., Offerhaus G.J., van Deventer S.J., et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007, 39:216-221.
400. van den Broek F.J., Fockens P., van Eeden S., Stokkers P.C., Ponsioen C.Y., Reitsma J.B., et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy 2011, 43:108-115.
401. Ignjatovic A., East J.E., Subramanian V., Suzuki N., Guenther T., Palmer N., et al. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol 2012, 107:885-890.
402. Pellisé M., López-Cerón M., Rodríguez de Miguel C., Jimeno M., Zabalza M., Ricart E., et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointest Endosc 2011, 74:840-848.
403. van den Broek F.J., Fockens P., van Eeden S., Reitsma J.B., Hardwick J.C., Stokkers P.C., et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut 2008, 57:1083-1089.
404. Wallace M.B., Meining A., Canto M.I., Fockens P., Miehlke S., Roesch T., et al. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther 2010, 31:548-552.
405. Gunther U., Kusch D., Heller F., Burgel N., Leonhardt S., Daum S., et al. Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. Int J Colorectal Dis 2011, 26:667-672.
406. Odze R.D., Tomaszewski J.E., Furth E.E., Feldman M.D., Diallo R., Poremba C., et al. Variability in the diagnosis of dysplasia in ulcerative colitis by dynamic telepathology. Oncol Rep 2006, 16:1123-1129.
407. Odze R.D., Goldblum J., Noffsinger A., Alsaigh N., Rybicki L.A., Fogt F. Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology. Mod Pathol 2002, 15:379-386.
408. Taylor B.A., Pemberton J.H., Carpenter H.A., Levin K.E., Schroeder K.W., Welling D.R., et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum 1992, 35:950-956.
409. Ullman T., Croog V., Harpaz N., Sachar D., Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003, 125:1311-1319.
410. Rutter M.D., Saunders B.P., Wilkinson K.H., Kamm M.A., Williams C.B., Forbes A. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004, 60:334-339.
411. Rubin D.T., Rothe J.A., Hetzel J.T., Cohen R.D., Hanauer S.B. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?. Gastrointest Endosc 2007, 65:998-1004.
412. Blonski W., Kundu R., Lewis J., Aberra F., Osterman M., Lichtenstein G.R. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?. Scand J Gastroenterol 2008, 43:698-703.
413. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003, 58:S3-S43.
414. Blonski W., Kundu R., Furth E.F., Lewis J., Aberra F., Lichtenstein G.R. High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis. Scand J Gastroenterol 2008, 43:817-820.
415. Odze R.D., Farraye F.A., Hecht J.L., Hornick J.L. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004, 2:534-541.
416. Rubin P.H., Friedman S., Harpaz N., Goldstein E., Weiser J., Schiller J., et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999, 117:1295-1300.
417. Engelsgjerd M., Farraye F.A., Odze R.D. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 1999, 117:1288-1294. [see comments], [Discussion].
418. Smith L.A., Baraza W., Tiffin N., Cross S.S., Hurlstone D.P. Endoscopic resection of adenoma-like mass in chronic ulcerative colitis using a combined endoscopic mucosal resection and cap assisted submucosal dissection technique. Inflamm Bowel Dis 2008, 14:1380-1386.
419. Vieth M., Behrens H., Stolte M. Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut 2006, 55:1151-1155.
420. Kisiel J.B., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Sandborn W.J. Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy. Inflamm Bowel Dis 2012, 18:226-235.
421. Torres C., Antonioli D., Odze R.D. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol 1998, 22:275-284.
422. Wanders L.K., Dekker E., Pullens B., Bassett P., Travis S.P., East J.E. Cancer risk following resection of polypoid dysplasia in patients with long-standing ulcerative colitis: a meta-analysis. Clin Gastroenterol Hepatol 2013, [in press].
423. Blackstone M.O., Riddell R.H., Rogers B.H., Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981, 80:366-374.
424. Borjesson L., Willen R., Haboubi N., Duff S.E., Hulten L. The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: a long-term term follow-up study. Colorectal Dis 2004, 6:494-498.
425. O'Riordain M.G., Fazio V.W., Lavery I.C., Remzi F., Fabbri N., Meneu J., et al. Incidence and natural history of dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of a five-year to ten-year follow-up. Dis Colon Rectum 2000, 43:1660-1665.
426. Gorgun E., Remzi F.H., Manilich E., Preen M., Shen B., Fazio V.W. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study. Surgery 2005, 138:631-637. [discussion 637-639].
427. Setti C., Talbot I.C., Nicholls R.J. Longterm appraisal of the histological appearances of the ileal reservoir mucosa after restorative proctocolectomy for ulcerative colitis. Gut 1994, 35:1721-1727.
428. Veress B., Reinholt F.P., Lindquist K., Lofberg R., Liljeqvist L. Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 1995, 109:1090-1097.
429. Gullberg K., Stahlberg D., Liljeqvist L., Tribukait B., Reinholt F.P., Veress B., et al. Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis. Gastroenterology 1997, 112:1487-1492.
430. Coull D.B., Lee F.D., Henderson A.P., Anderson J.H., McKee R.F., Finlay I.G. Risk of dysplasia in the columnar cuff after stapled restorative proctocolectomy. Br J Surg 2003, 90:72-75.